| Period Ending | Mar 31, 2012 | Mar 31, 2011 | Mar 31, 2010 |
|---|
|
Total Revenue
|
30,710,000
|
30,124,000
|
31,712,000
| | Cost of Revenue | 1,940,000 | 2,001,000 | 2,422,000 | | |
Gross Profit
|
-
|
-
|
-
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
|
Selling General and Administrative | 17,812,000 | 17,212,000 | 16,336,000 |
|
Non Recurring | 68,000 | 113,000 |
-
|
|
Others | (280,000) | 8,000 | 2,377,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
| | | |
Operating Income or Loss
|
-
|
-
|
-
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 11,514,000 | 11,169,000 | 10,905,000 |
|
Interest Expense | 3,115,000 | 3,414,000 | 3,231,000 |
|
Income Before Tax | 8,054,000 | 7,376,000 | 7,346,000 |
|
Income Tax Expense | 169,000 | 2,331,000 | (3,855,000) |
|
Minority Interest | 90,000 | (66,000) | (503,000) |
|
|
|
Net Income From Continuing Ops | 7,976,000 | 4,979,000 | 10,699,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
| | | |
Net Income
|
7,976,000
|
4,979,000
|
10,699,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
7,976,000
|
4,979,000
|
10,699,000
|
|